ARTICLE | Clinical News
L-leucine plus metformin: Phase IIa started
August 18, 2014 7:00 AM UTC
NuSirt began a double-blind, U.S. Phase IIa trial to compare oral fixed-dose combinations of 1.1 g L-leucine with 125, 250 or 500 mg metformin twice daily for 4 weeks vs. 500 mg oral metformin twice d...